Summit Therapeutics (SMMT) Interest Coverage Ratio (2017 - 2024)
Summit Therapeutics (SMMT) posted quarterly Interest Coverage Ratio of 8.98 for Q4 2024, up 27.1% year-on-year from 7.07 in Q1 2024, and up 62.23% on a QoQ basis from 23.78 in Q3 2024.
Summit Therapeutics (SMMT) Interest Coverage Ratio (2017 - 2024) Analysis & Trends
Summit Therapeutics (SMMT) has reported Interest Coverage Ratio for 8 consecutive years, with 8.98 the latest figure, recorded in Q4 2024.
- Quarterly Interest Coverage Ratio rose 27.1% year-over-year to 8.98 in Q4 2024, while the trailing twelve-month figure through Dec 2024 was 14.14 (up 59.01% YoY) and the FY2024 annual result came in at 0.13, up 98.13% from the prior year.
- Interest Coverage Ratio rose to 8.98 in Q4 2024 per SMMT's latest filing, from 23.78 in the prior quarter.
- Over the last five years, Interest Coverage Ratio for SMMT reached as high as 13023.5 in Q4 2021 and fell as low as 626.78 in Q1 2021.
- A 5-year average of 747.79 and a median of 19.33 in 2022 frame the typical range for Interest Coverage Ratio.
- Annual changes were most pronounced in 2021 — Interest Coverage Ratio soared 28838.25% — and 2024, when it slumped 324.44%.
- Year by year, Interest Coverage Ratio stood at 45.32 in 2020, then surged by 28838.25% to 13023.5 in 2021, then plunged by 100.19% to 24.48 in 2022, then surged by 49.67% to 12.32 in 2023, then increased by 27.1% to 8.98 in 2024.
- According to Business Quant data, Interest Coverage Ratio over the past three periods registered 8.98, 23.78, and 19.22 for Q4 2024, Q3 2024, and Q2 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 7.60 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -0.22 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -0.38 |
| 10 | Summit Therapeutics | 11.62 Bn | 11.03 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -8.98 |
| Sep 30, 2024 | -23.78 |
| Jun 30, 2024 | -19.22 |
| Mar 31, 2024 | -13.58 |
| Dec 31, 2023 | -12.32 |
| Sep 30, 2023 | -7.03 |
| Jun 30, 2023 | -4.53 |
| Mar 31, 2023 | -64.51 |
| Sep 30, 2022 | -24.48 |
| Jun 30, 2022 | -19.44 |
| Mar 31, 2022 | -74.61 |
| Dec 31, 2021 | 13,023.50 |
| Jun 30, 2021 | -109.86 |
| Mar 31, 2021 | -626.78 |
| Dec 31, 2020 | -45.32 |
| Sep 30, 2020 | -4.46 |
| Dec 31, 2019 | 32.67 |
| Oct 31, 2019 | -306.13 |
| Jul 31, 2019 | -267.40 |
| Mar 31, 2019 | -286.18 |